Predictors of treatment nonresponse in bipolar children and adolescents with manic or mixed episodes
- PMID: 15650495
- DOI: 10.1089/cap.2004.14.395
Predictors of treatment nonresponse in bipolar children and adolescents with manic or mixed episodes
Abstract
Even though juvenile bipolar disorder (BD) is reported to be more treatment-resistant than adult BD, predictors of nonresponse are not well studied. The aim of this study was to address this issue in a naturalistic sample of bipolar children and adolescents with manic or mixed episodes treated under the condition of routine clinical practice. This study was comprised of 40 patients (19 females and 21 males; mean age, 14.2 years; SD = 3.3; range, 7-18) with a Diagnostic and Statistical Manual of Mental Disorders-fourth edition (DSM-IV) diagnosis of manic (n = 23) or mixed episodes (n = 17). The clinical characteristics of 20 patients considered to be treatment responders, according to the Clinical Global Impression-Improvement (CGI-I) scores, were compared to those of the 20 nonresponders. The effect of predictors on the probability of treatment nonresponse was analyzed using the multiple stepwise logistic regression, backward procedure. Demographic variables (mean age, gender ratio, socioeconomic status), as well as the inpatients-outpatients ratio (75% versus 65%), duration of the follow-up (10.5 +/- 2.5 months versus 9.6 +/- 3.2 months), index episode (manic versus mixed), and rates of pharmacologic hypomania did not differentiate the 2 groups. According to stepwise logistic regression, predictors of nonresponse were the presence of comorbidity with conduct disorder (odd ratio, 3.36; 95% CI, 2.20-4.52), attention deficit hyperactivity disorder (ADHD) (odd ratio, 2.30; CI, 1.24-3.26), and the baseline CGI Severity score (odd ratio, 2.31; CI, 1.33-3.29). It is relevant to point out that patient age at the onset of BD, and at the first visit, and comorbid anxiety disorders did not influence treatment response. Follow-up studies with a larger sample size with BD and/or externalizing disorders appropriately managed with different treatment options and/or combinations are warranted.
Similar articles
-
Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents.Bipolar Disord. 2006 Aug;8(4):373-81. doi: 10.1111/j.1399-5618.2006.00342.x. Bipolar Disord. 2006. PMID: 16879138
-
Predictors of remission in 208 drug-resistant depressive patients treated with electroconvulsive therapy.J ECT. 2014 Dec;30(4):292-7. doi: 10.1097/YCT.0000000000000119. J ECT. 2014. PMID: 24625706
-
Clinical and research implications of panic-bipolar comorbidity in children and adolescents.Psychiatry Res. 2007 Sep 30;153(1):47-54. doi: 10.1016/j.psychres.2006.10.010. Epub 2007 Jun 28. Psychiatry Res. 2007. PMID: 17602754
-
ECNP consensus meeting. Bipolar depression. Nice, March 2007.Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Eur Neuropsychopharmacol. 2008. PMID: 18501566 Review.
-
[Attention-deficit hyperactivity disorder or bipolar disorder in childhood?].Psychiatriki. 2012 Oct-Dec;23(4):304-13. Psychiatriki. 2012. PMID: 23399752 Review. Greek, Modern.
Cited by
-
Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder.J Child Adolesc Psychopharmacol. 2011 Dec;21(6):545-53. doi: 10.1089/cap.2010.0140. Epub 2011 Dec 2. J Child Adolesc Psychopharmacol. 2011. PMID: 22136096 Free PMC article. Clinical Trial.
-
A Naturalistic Study of Youth Referred to a Tertiary Care Facility for Acute Hypomanic or Manic Episode.Brain Sci. 2020 Sep 29;10(10):689. doi: 10.3390/brainsci10100689. Brain Sci. 2020. PMID: 33003515 Free PMC article.
-
Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.BMC Psychiatry. 2010 Sep 28;10:74. doi: 10.1186/1471-244X-10-74. BMC Psychiatry. 2010. PMID: 20875144 Free PMC article.
-
Effectiveness of lithium in children and adolescents with conduct disorder: a retrospective naturalistic study.CNS Drugs. 2009;23(1):59-69. doi: 10.2165/0023210-200923010-00004. CNS Drugs. 2009. PMID: 19062775 Clinical Trial.
-
Quetiapine monotherapy in adolescents with bipolar disorder comorbid with conduct disorder.J Child Adolesc Psychopharmacol. 2013 Oct;23(8):568-71. doi: 10.1089/cap.2013.0063. J Child Adolesc Psychopharmacol. 2013. PMID: 24138010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical